Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: A preliminary study

Neuropsychiatric Disease and Treatment

Volumn 7, Issue 1, 2011, Pages 495-499

  Sailasuta, Napapon ^a   Harris, Kent ^a   Tran, Thao ^a   Ross, Brian ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Alzheimer's disease; Glial activation; Noninvasive biomarker

Indexed keywords

ACETIC ACID C 13; BICARBONATE; GLUTAMIC ACID; GLUTAMINE; STABLE ISOTOPE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; BIOSYNTHESIS; BRAIN METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ACTIVATION; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ENCEPHALITIS; FEMALE; GLIA CELL; HUMAN; ISOTOPE LABELING; MALE; METABOLIC RATE; MINIMALLY INVASIVE PROCEDURE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OXIDATION; QUANTITATIVE ANALYSIS;

EID: 80955132633     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/ndt.s23721     Document Type: Article

References (33)

1. Kim S, Swaminathan S, Shen L, et al. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011;76(1):69-79.
2. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol. 2011;121(5):597-609.
3. Krause DL, Muller N. Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis. 2010;2010:732806.
4. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119-128.
5. Godbolt AK, Waldman AD, MacManus DG, et al. MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology.2006;66(5):718-722.
6. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R. In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem. 1997;68(1-3):161-172.
7. Ross BD, Danielsen ER, Bluml S. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis. 1996;14(Suppl 1):30-39.
8. Ross B, Tran T, Bhattacharya P, Watterson DM, Sailasuta N. Application of NMR spectroscopy in medicinal chemistry and drug discovery. Curr Top Med Chem. 2011;11(1):93-114.
9. Ross B, Lin A, Harris K, Bhattacharya P, Schweinsburg B. Clinical experience with 13C MRS in vivo. NMR Biomed. 2003;16(6-7): 358-369.
10. Lebon V, Petersen KF, Cline GW, et al. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci. 2002;22(5):1523-1531.
11. Rothman DL, Behar KL, Hyder F, Shulman RG. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol. 2003;65:401-427.
12. Bluml S, Moreno A, Hwang JH, Ross BD. 1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed. 2001;14(1):19-32.
13. Bluml S, Moreno-Torres A, Shic F, Nguy CH, Ross BD. Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed.2002;15(1):1-5.
14. Sailasuta N, Abulseoud O, Harris KC, Ross BD. Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab.2010;30(5):950-960.
15. Van den Berg CJ, Krzalic L, Mela P, Waelsch H. Compartmentation of glutamate metabolism in brain. Evidence for the existence of two different tricarboxylic acid cycles in brain. Biochem J. 1969;113(2): 281-290.
16. Wyss MT, Magistretti PJ, Buck A, Weber B. Labeled acetate as a marker of astrocytic metabolism. J Cereb Blood Flow Metab. 2011 June 8.[Epub ahead of print.]
17. Muir D, Berl S, Clarke DD. Acetate and fluoroacetate as possible markers for glial metabolism in vivo. Brain Res. 1986;380(2):336-340.
18. Boumezbeur F, Mason GF, de Graaf RA, et al. Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 2010;30(1):211-221.
19. Sailasuta N, Tran TT, Harris KC, Ross BD. Swift Acetate Glial Assay (SAGA): an accelerated human (1)(3)C MRS brain exam for clinical diagnostic use. J Magn Reson. 2010;207(2):352-355.
20. Strauss EH, Sherman EMS, Spreen O. A compendium of neuropsychological tests. 3rd ed. New York: Oxford University Press; 2006.
21. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194.
22. Sailasuta N, Robertson LW, Harris KC, Gropman AL, Allen PS, Ross BD. Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe. J Magn Reson. 2008;195(2):219-225.
23. Sailasuta N, Abulseoud O, Hernandez M, Haghani P, Ross BD. Metabolic abnormalities in abstinent methamphetamine dependent subjects. Subst Abuse. 2010;2010(4):9-20.
24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6): 672-679.
25. Eden A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslen M. Immune activation of the central nervous system is still present after.4 years of effective highly active antiretroviral therapy. J Infect Dis. 2007;196(12):1779-1783.
26. Von Giesen HJ, Wittsack HJ, Wenserski F, Koller H, Hefter H, Arendt G. Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol. 2001;58(8):1281-1286.
27. Sekine Y, Ouchi Y, Sugihara G, et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci. 2008;28(22): 5756-5761.
28. Miguel-Hidalgo JJ. The role of glial cells in drug abuse. Curr Drug Abuse Rev. 2009;2(1):72-82.
29. Hilton GD, Stoica BA, Byrnes KR, Faden AI. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab. 2008;28(11):1845-1859.
30. Graber DJ, Hickey WF, Harris BT. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflammation.2010;7:8.
31. Eikelenboom P, Bate C, Van Gool WA, et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia. 2002;40(2):232-239.
32. McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(5): 741-749.
33. Lin AP, Shic F, Enriquez C, Ross BD. Reduced glutamate neurotransmission in patients with Alzheimer's disease - an in vivo (13)C magnetic resonance spectroscopy study. MAGMA. 2003;16(1):29-42.